315
6 months. There was a palpable tight fibrous band over the left buc-
cal mucosa. Computed tomography scan reported of an ill-defined
soft tissue mass in the left oropharynx region involving the left
medial and lateral pterygoid muscle, infratemporal fossa, tempo-
ralis muscle, maxilla, ramus of mandible and extends into the left
parapharyngeal space. Histopathology examination reported the
lesion as plasmacytoma and her bone marrow trephine result was
negative for myeloma. She was diagnosed with extramedullary
plasmacytoma of the left oropharynx. She completed the radio-
therapy treatment, and currently she is free of disease for two
years.
Conclusion:
Extramedullary plasmacytoma often occur in the
posterior mandible region and frequently occurs within themucosa
of the oral cavity and pharynx. It has a favourable prognosis of
70% 10-year survival (Weber DM, 2005).
http://dx.doi.org/10.1016/j.ijom.2017.02.1060Expression of fibroblast growth factor receptor type 2 in
primary and recurrent ameloblastoma are correlated with
ameloblastoma clinic characteristics
Y. Tang
∗
, T. Ji
Department of Oral Maxillofacial and Head Neck Oncology,
Ninth People’s Hospital, Shanghai JiaoTong University School
of Medicine, China
Background:
Fibroblast growth factor receptor type 2 (FGFR2),
a receptor tyrosine kinase, is involved in a number of cell
signalling pathways that contribute to cell growth and differentia-
tion. Whether it presence in primary ameloblastoma and recurrent
ameloblastoma has not been previously investigated.
Objectives:
This study was undertaken to detect the immunohis-
tochemical expression of the FGFR2 in primary ameloblastoma
and recurrent ameloblastoma, and to determine if it was involved
in the development of ameloblastoma, especially in the invasion
and recurrence of ameloblastoma.
Methods:
In this study, 96 formalin-fixed, paraffin-embedded tis-
sue blocks of ameloblastoma specimens which come from patients
with two surgery and patients with only one surgery were com-
pared at protein expression level using immunohistochemistry for
FGFR2 staining.
Finding:
The results indicated that, FGFR2 immunostaining was
evident in all groups of the specimens, the staining in recurrence
ameloblastoma was stronger than in primary ameloblastoma.
Statistical analysis showed that FGFR2 expression levels were
significantly higher in recurrence ameloblastoma than in primary
ameloblastoma, and the patient with tumour size over 3 cm had a
higher rate of recurrence.
Conclusion:
Our study suggests that the high expression rate of
FGFR2 plays an important role in the invasion and recurrence of
ameloblastoma.
http://dx.doi.org/10.1016/j.ijom.2017.02.1061Clinical feature of Sjögren’s syndrome in our hospital
comparison of the Japanese criteria with the internationally
approved criteria edited by American College of
Rheumatology
S. Tsuchida
∗
, A. Nagayama, D. Uchida, H. Kawamata
Department of Oral and Maxillofacial Surgery, Dokkyo Medical
University School of Medicine, Tochigi, Japan
Background:
The revised criteria for the diagnosis of Sjögren’s
syndrome (SS) issued by the Japanese Ministry of Health study
group (JPN) is usually used in daily clinical practice and clin-
ical study for SS in Japan. On the other hands, the American
College of Rheumatology (ACR) classification criteria for SS are
internationally used.
Objectives:
We reported the clinical feature of Sjögren’s syn-
drome in our hospital, and examined the characteristics of JPN
criteria when compared with ACR criteria.
Methods:
248 patients diagnosed with SS by the JPN criteria in
our Hospital from 2007 to 2015 were retrospectively re-diagnosed
by ACR criteria, and were examined the difference and the char-
acteristics of these diagnosis criteria.
Findings:
70 (28%) patients diagnosed by JPN criteria did not
meet ACR criteria. Nine patients who met JPN histopathologi-
cal criteria did not fulfil ACR criteria. Conversely, two patients
who met ACR histopathological criteria did not fulfil JPN crite-
ria. Five patients who met ACR serological criteria did not fulfil
JPN criteria.
Discussion and Conclusion:
Relative sensitivity of JPN crite-
ria might be higher than that of ACR criteria, conversely relative
specificity of ACR criteria might be higher than that of JPN crite-
ria. Because SS was developed based on autoimmune disorder,
when the disease was diagnosed by only clinical signs and symp-
tom, such as dry mouth and dry eyes without any serological
and histopathological abnormality, the diagnosis would be over-
diagnosis. We should understand the characteristics of several
diagnosis criteria for SS, and utilise these criteria to reach true
SS.
http://dx.doi.org/10.1016/j.ijom.2017.02.1062A case of spontaneous regression of plasmablastic lymphoma
in the upper gingiva
M. Yao
∗
, N. Yoshioka, K. Hasegawa, T. Shimo, A. Sasaki
Okayama University Graduate School of Medicine, Dentistry
and Pharmaceutical Sciences, Japan
Background:
Plasmablastic lymphoma (PBL) is a rare, aggres-
sive neoplasm that most commonly occurs in immunodeficient
patients. The most common site of PBL is the oral cavity and the
prognosis is poor. Spontaneous regression of malignant lymphoma
is extremely unusual. Here, we report a spontaneous regression of
PBL in the upper gingiva without any treatment.
Case Report:
An 80-year-old male was referred with a swelling
at the right upper gingiva. He had been extracted the second
molar at the same side before two months at a private dental
clinic. Computed tomography (CT) scan demonstrated a mass
involving alveolar bone at the right upper molar region. Positron
emission tomography-CT showed hypermetabolic lesion on the
right side of the maxilla with increased fluorodeoxyglucose uptake




